Skip to main content
PLOS One logoLink to PLOS One
. 2023 May 2;18(5):e0284117. doi: 10.1371/journal.pone.0284117

The burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among patients in Bangladesh

Rashidul Alam Mahumud 1,2,3,*, Jeff Gow 3,4, Md Parvez Mosharaf 1,3, Satyajit Kundu 5,6, Md Ashfikur Rahman 7, Natisha Dukhi 8, Md Shahajalal 9, Sabuj Kanti Mistry 10,11,12,13, Khorshed Alam 3
Editor: Tarik A Rashid14
PMCID: PMC10153713  PMID: 37130132

Abstract

Background

Chronic diseases are considered one of the major causes of illness, disability, and death worldwide. Chronic illness leads to a huge health and economic burden, especially in low- and middle-income countries. This study examined disease-stratified healthcare utilisation (HCU) among Bangladesh patients with chronic diseases from a gender perspective.

Methods

Data from the nationally representative Household Income and Expenditure Survey 2016–2017 consisting of 12,005 patients with diagnosed chronic diseases was used. Gender differentiated chronic disease stratified-analytical exploration was performed to identify the potential factors to higher or lower utilisation of healthcare services. Logistic regression with step-by-step adjustment for independent confounding factors was the method used.

Results

The five most prevalent chronic diseases among patients were gastric/ulcer (Male/Female, M/F: 16.77%/16.40%), arthritis/rheumatism (M/F: 13.70%/ 13.86%), respiratory diseases/asthma/bronchitis (M/F: 12.09% / 12.55%), chronic heart disease (M/F: 8.30% / 7.41%), and blood pressure (M/F: 8.20% / 8.87%). Eighty-six percent of patients with chronic diseases utilised health care services during the previous 30 days. Although most patients received outpatient healthcare services, a substantial difference in HCU among employed male (53%) and female (8%) patients were observed. Chronic heart disease patients were more likely to utilise health care than other disease types, which held true for both genders while the magnitude of HCU was significantly higher in males (OR = 2.22; 95% CI:1.51–3.26) than their female counterparts (OR = 1.44; 1.02–2.04). A similar association was observed among patients with diabetes and respiratory diseases.

Conclusion

A burden of chronic diseases was observed in Bangladesh. Patients with chronic heart disease utilised more healthcare services than patients experiencing other chronic diseases. The distribution of HCU varied by patient’s gender as well as their employment status. Risk-pooling mechanisms and access to free or low-cost healthcare services among the most disadvantaged people in society might enhance reaching universal health coverage.

Background

Chronic diseases are the leading causes of death globally [1]. Estimates suggest that chronic diseases cause approximately 41 million deaths annually, equivalent to 71% of all deaths globally [2]. Each year, more than 15 million people die from a chronic disease who are aged between 30 and 69 years; 85% of these “premature” deaths occur in low- and middle- income countries [2]. The major chronic diseases are ischaemic heart disease, stroke, chronic obstructive pulmonary disease (COPD) and diabetes [3]. Notably, 75% of deaths from chronic diseases are associated with modifiable risk factors (e.g., tobacco use, physical inactivity, the harmful use of alcohol and unhealthy diets). The burden of chronic diseases adversely impacts individuals, communities, and families, resulting in health systems being overwhelmed and incurring large socioeconomic costs [2]. Therefore, investing in chronic disease detection, screening, treatment, and palliative care are vital components of an effective response to achieve the 2030 Agenda for Sustainable Development Goal (SDG) 3.4: reducing premature deaths by one-third by 2030 [4].

Bangladesh is a developing country that is undergoing both epidemiologic and demographic transitions, where the disease burden is shifting from an infectious disease dominated illness profile to a highly characterised chronic diseases profile, coupled with socioeconomic inequality and occurring in predominantly rural populations [5, 6]. Chronic diseases account for approximately 61% of total burden of disease and 54% of annual mortality in Bangladesh, with diabetes, cardiovascular disease, chronic respiratory disease, cancer, and stroke most common illnessess [7, 8]. The global burden of disease country profile for Bangladesh highlights a trend of increased chronic disease mortality due to stroke, ischaemic heart disease, chronic kidney disease, chronic pulmonary disease and diabetes [9]. A recent study suggested that the prevalence of double and triple burden of chronic disease in Bangladesh is 21.4% and 6.1%, respectively [10]. A survey of the non-communicable disease (NCD) risk factors survey in 2010 indicated that approximately 99% of population had at least one NCD risk factors [11]. In their disease risk factor survey in 2010, the WHO indicated that the death rate from only cardiovascular disease will be increased 21 times in Bangladesh by 2025 where a study suggested 53.7% rural elderly population had chronic comorbid conditions [12]. Significant challenges to managing this situation exist such as a highly unregulated private health sector and a weak public health system must be addressed in conjunction with the ongoing increase in chronic diseases. With more than 70% of the population residing in rural areas, access to formal healthcare services are minimal due to an urban treatment bias and out-of-pocket expenditure is high with minimal health insurance coverage [13, 14]. HCU is often compounded by high treatment costs, limited access to proper care, inadequate or lack of infrastructure, and socioeconomic gaps [6]. Evidence also indicates that households with individuals with one or more chronic diseases face significantly higher financial risks [15, 16].

Adopting a gendered approach to chronic diseases management is an imperative, as men and women function different biologically and therefore face different health risks, experience different health system responses, and their health-seeking behaviours differ, all impacting their health outcomes as well as HCU [17, 18]. The literature shows that due to lower social status, limited education access, and economic vulnerability, women are disproportionately affected than men in their HCU [19]. In one Indian study, older women reported decreased HCU compared to their male counterparts, resulting in worse self-rated health and higher disability prevalence among them [20]. A study in Canada conversely found that women utilise healthcare services much more than men and spend more on healthcare [21]. A recent study found that women are lagging behind than their male counterparts in utilising inpatient care for chronic diseases such as diabetes, hypertension, chronic lung disease, depression, stroke, and asthma [21]. This study also identified males were willing to travel greater distances to access better-equipped healthcare facilities than women who tend to seek inpatient care at facilities near their homes.

There are still gender disparities in decision-making, roles and rights at home, and self-esteem when it comes to empowering women, which limits their access to healthcare in developing countries [2022]. This is also true for Bangladesh, where men are often viewed as the head of households, decision-makers and are usually in charge of household resources and who typically decide on the women’s health needs and where and when they should utilise healthcare services [20, 22]. To achieve SDG 5: Health and gender equality, it is imperative to ensure women have access to appropriate health care utilisation [20, 22]. However, there is scant information on existing gender disparities in utilising healthcare services among patients with chronic diseases in Bangladesh.

As a result, this study aimed to examine the gender perspective of HCU among patients with chronic diseases in Bangladesh.

Methods

Study design and data source

This cross-sectional study used data from a nationally representative survey, the Household Income and Expenditure Survey (HIES) in Bangladesh. The HIES is commonly used worldwide, especially in developing countries, to assess poverty levels and people’s living standards. The HIES survey collects information about each household income, expenditure, consumption, health and social safety and other socio-economic aspects [23]. HIES in Bangladesh is a periodic cross-sectional survey conducted every five years by the Bangladesh Bureau of Statistics (BBS). The present study used data from the most recent HIES conducted in 2016–2017. Bangladesh Bureau of Statistics (BBS) has already validated the study settings and tested the reliability of the data [23]. The details of the study settings, questionnaire, and quality control measures have been described in the HIES 2016–17 report summary [23]. The HIES 2016–17 survey was based on an established protocol [23]. The HIES is a cross-sectional survey conducted by the BBS in Bangladesh every five (5) years since 1973; throughout the period of implementation, the HIES tools have been thoroughly reviewed to address the validity and reliability of the results. In line with the objective of HIES survey, the HIES 2016–17 survey collected information under nine modules: 1) household information, 2) education, 3) health: illnesses and injuries, 4) economic activities and wage employment, 5) non-agricultural enterprises, 6) housing, 7) agriculture, 8) other assets and income, and 9) consumption. However, the objective of the current article was to investigate disease-stratified healthcare utilisation (HCU) among Bangladesh patients with chronic diseases from a gender perspective. Therefore, we only use the indicators pertaining to chronic disease and health service utilisation along with socio-demographic characterises of the participants. The HIES datasets are widely accepted and validated to produce scientific evidence. It is also used for monitoring the progress of poverty reduction and the Sustainable Development Goals (SDGs) indicators in Bangladesh.

Sampling

A stratified, two-stage random sample design was adopted for the data collection. In the first stage, primary sampling units (PSUs) throughout the country from 20 strata (8 rural, 8 urban, and 4 metropolitan areas) were randomly selected to achieve national representation. A total of 2304 PSUs were selected using systematic random sampling from the list of 2011 Housing and Population Census enumeration areas. A PSU is usually a geographically constructed area, or a part of an area, called an enumeration area (EA), containing a number of households, created from the most recent population census. In the second stage, 20 households within each PSU were randomly selected (BBS, 2016). Using this sampling technique, a total of 46,080 households were included in HIES 2016–2017. Among the selected households, a total of 186,076 individuals were interviewed. Data collection was performed between April 1, 2016 and 31 March 2017. The survey objectives, sampling technique, survey design, survey instruments, measuring system, and quality control have been described elsewhere [23].

Participants selection criteria:

The participants for the current analysis were selected based on the following inclusion criteria: (1) an individual who suffered from any chronic illness in the last 12 months, (2) individual who received any treatment due to chronic illness in the last 30 days at the interview time, and iii) individual who received any treatment due to chronic illness in the last 30 days. Based on these inclusion criteria, a total of 12,005 participants were selected for analytical exploration in this study (Fig 1).

Fig 1. Sample selection.

Fig 1

Study variables

Outcome measure

This study considered ‘patient’s utilisation of healthcare services due to chronic illness as an outcome variable. As a measure of their HCU related to chronic illness, participants responded to questions that asked them about any type of medical treatment: “Have you sought any type of medical treatment related to your illness in the last 30 days?” Response options were recoded as dichotomous (‘yes’ if the patient received any type of medical treatment due to illness, or ‘no’ otherwise).

Chronic diseases

All health-related information was self-reported in the HIES survey. For conducting the analysis, we used chronic disease-related questions that were included in Module-3: Health (Illnesses and Injuries) of the primary survey [23]. For example, while collecting chronic disease-related information, the enumerators were instructed to ask the respondents, "Have you suffered from any chronic illness/disability in the last 12 months or more?" (if yes); then, participants were asked a second question “What chronic illness/disability are you suffering from?” with response options: 1) chronic fever, 2) Injuries/disability, 3) Chronic heart disease, 4) Respiratory Diseases/ Asthma/Bronchitis, 5) Diarrhoea/dysentery, 6) Gastric/ulcer, 7) Blood pressure, 8) Arthritis/Rheumatism, 9) Skin problem, 10) Diabetes, 11) Cancer, 12) Kidney diseases, 13) Liver Diseases, 14) Mental Health, 15) Paralysis, 16) Ear/ENT problem, 17) Eye problem, or 18 other (specify). Participants responded based on their disease diagnosis, experiences, symptoms of illness and course of treatment. For analysis, we recorded type of diseases based on the most reported but kidney diseases had a low frequency ones (Fig 2).

Fig 2. Distribution of chronic illness.

Fig 2

The explanatory variables considered in the study were demographic characteristics (gender, age, marital status, education, employment); type of chronic disease (e.g., chronic heart disease, respiratory diseases, gastric or ulcer, blood pressure, arthritis or rheumatism, diabetes, chronic fever, and other diseases); number of chronic comorbid conditions (one chronic condition, two chronic comorbid conditions and three or more chronic comorbid conditions); type of healthcare provider (public hospital, private clinic or hospital, pharmacy/dispensary, doctor’s chamber, or others), type of healthcare services (inpatient or outpatient care); and location of the consulted healthcare provider (urban or rural).

Statistical analysis

In the descriptive analyses analysis, characteristics of the study participants were expressed using frequencies, n (%). The dependent variable (i.e., utilisation of health care services: chronic illness patients who received any type of medical treatment due to chronic illness in the last 30 days) was characterised as a dichotomous measure. For the analytical exploration, the choice of estimation approach was informed by the nature of the outcome variables under consideration in each model. The logistic regression model was used to identify the potential factors that had a significant role in utilising healthcare services. The potential factors of utilising healthcare services owing to chronic illness were investigated using binary logistic regression models, with the results provided as odd ratios (OR) [i.e., exponential form of regression coefficient, OR = exp (beta)] and 95% confidence intervals. The regression model can be expressed as-

logit(Yi)=α+β1X1i+β2X2i++i

Where ‘Yi is the dichotomous outcome variable (i.e., utilisation of healthcare services at the last 30 days due to chronic illness), β1, β2, …. are the regression coefficients for the corresponding explanatory variables; X1i, X2i…..denote explanatory variables; and ϵi is the error term.

Utilisationofhealthcareservices(Yi)={0,ifanindividualdidnotreceivehealthcareservices1,ifanindividualreceivedhealthcareservices

To build the regression model, explanatory variables were selected based on published literature [16, 2428], available variables of this dataset and explored bivariate relationships (unadjusted analysis) between variables. In our analysis, we investigated individual-level data to estimate disease-specific healthcare utilisation due to chronic illness by gender prospective.

The majority of the predictor variables were categorical in nature with two or more labels in this study. Therefore, an un-adjusted analysis was performed to find the association between outcome and the label of explanatory variables (Model 1). Our analyses were stratified by chronic diseases and gender prospective. For all diseases, the unadjusted explorations were expressed in Model 1, where most of the patients with chronic diseases were found to be significantly associated with lower or higher health care utilisation for both genders (all p ≤ 0.05). After step-by-step adjustment of independent confounding factors, we adjusted different variables into seven different models (i.e., variable related to type of health care was adjusted in Model 2). These were performed to present the variables that were significant in Models 2 to Model 7, in order to understand how those variables are modified in the final model where all the variables were adjusted at the same time in the final Model 8.

For the independent variables, the category found to be least at risk of having patients’ health care services related to chronic illness in the analysis was considered the reference category for constructing OR. We have followed standard ‘svy’ prefix command to address sampling weights. In addition, before running the final model, we checked for multicollinearity using Variance inflation factor (VIF) among the selected variables, no serious issues multicollinearity were found among the variables (all variables with VIF <5.00). The model was tested for sensitivity using the bootstrapping approach by resampling observations with 10,000 replications. Statistical significance was considered at ≤ 5% risk level. All data analyses were undertaken using the statistical software Stata/SE 14 (StataCorp, College Station, TX, USA).

Ethical approval

The datasets were collected and made publicly available by the Bangladesh Bureau of Statistics (BBS). Since the de-identified data for this study came from secondary sources, this study did not require ethical approval.

Results

Participants’ characteristics and distribution of chronic diseases

The total sample consisted of 12,005 patients (⁓ 50% of male) with one or more medically diagnosed chronic diseases (Table 1). 42% of male patients were young adults (18 to 45 years), and approximately 50% were married. However, one-third of patients had no formal education. Fifty-three percent of male patients were employed in the labour force, whereas only eight percent of female patients were employed. Most patients (94% of male and 92% of female) respondents reported at least one disability. The five most prevalent chronic diseases among multimorbid patients were gastric/ulcer (Male/Female (M/F):16.77% / 16.40%), arthritis/rheumatism (M/F:13.70% / 13.86%), respiratory diseases/asthma/bronchitis (M/F: 12.09% / 12.55%), chronic heart diseases (M/F: 8.30% / 7.41%), and blood pressure (M/F: 8.20% / 8.87%). We did not report the prevalence of all diseases due to low frequency (Fig 2). Most of the patients utilised outpatient health care services, with two-third of patients receiving health care from private hospitals or clinics usually in rural locations. 83% of patients reported 30 minutes (overall) or less waiting time to receive health care services.

Table 1. Distribution of patient’s characteristics and utilisation of health care services, by gender.

Participant characteristics Male patients Female patients
Number of patients, n (%) Utilisation of healthcare, % (95% CI) Number of patients, n (%) Utilisation of healthcare, % (95% CI)
Age in years    
<18 years 2,292 (38.28) 38.21 (36.9, 39.54) 2,210 (36.72) 36.82 (35.51, 38.14)
18–35 years 1,748 (29.20) 29.07 (27.85, 30.32) 2,011 (33.42) 33.28 (32.01, 34.57)
36–45 years 778 (12.99) 12.86 (11.97, 13.80) 715 (11.88) 11.8 (10.95, 12.70)
46–64 years 859 (14.35) 14.75 (13.81, 15.74) 806 (13.39) 13.24 (12.35, 14.19)
65 or more 310 (5.18) 5.11 (4.54, 5.74) 276 (4.59) 4.87 (4.32, 5.49)
Educational background    
No education 2,208 (36.88) 36.78 (35.48, 38.11) 2,190 (36.39) 36.24 (34.94, 37.56)
Up to primary 1,739 (29.05) 28.94 (27.72, 30.19) 1,776 (29.51) 29.58 (28.35, 30.84)
Secondary education 1,608 (26.86) 26.97 (25.78, 28.20) 1601 (26.60) 26.56 (25.38, 27.78)
Higher 432 (7.22) 7.31 (6.63, 8.05) 451 (7.49) 7.62 (6.93, 8.38)
Marital status    
Currently married 2,961 (49.46) 49.55 (48.19, 50.91) 3,164 (52.58) 52.54 (51.18, 53.90)
Never married 2,258 (37.72) 37.69 (36.38, 39.02) 1,657 (27.53) 27.21 (26.02, 28.44)
Widowed/divorced/separated 768 (12.83) 12.76 (11.88, 13.70) 1197 (19.89) 20.25 (19.18, 21.36)
Religion status    
Islam 5,188 (86.65) 86.81 (85.86, 87.71) 5,222 (86.77) 86.97 (86.03, 87.86)
Hinduism 601 (10.04) 9.95 (9.16, 10.79) 595 (9.89) 9.95 (9.16, 10.79)
Others 198 (3.31) 3.24 (2.79, 3.76) 201 (3.34) 3.08 (2.64, 3.59)
Employed status    
Employed 3,196 (53.38) 53.2 (51.80, 54.50) 491 (8.16) 7.81 (7.11, 8.58)
Unemployed 2,791 (46.62) 46.8 (45.50, 48.20) 5,527 (91.84) 92.19 (91.42, 92.89)
Any type of disability    
Yes 5,636 (94.14) 94.04 (93.36, 94.66) 5,560 (92.39) 92.42 (91.67, 93.11)
No 351 (5.86) 5.96 (5.34, 6.64) 458 (7.61) 7.58 (6.89, 8.33)
Type of chronic illness    
Chronic heart disease 497 (8.30) 8.96 (8.22, 9.77) 446 (7.41) 7.78 (7.08, 8.54)
Respiratory diseases/ Asthma/Bronchitis 724 (12.09) 12.53 (11.66, 13.46) 755 (12.55) 12.86 (11.97, 13.79)
Gastric/ulcer 1,004 (16.77) 16.04 (15.07, 17.06) 987 (16.40) 15.78 (14.82, 16.8)
Blood pressure 491 (8.20) 8.31 (7.59, 9.09) 534 (8.87) 8.83 (8.09, 9.64)
Arthritis/Rheumatism 820 (13.70) 13.69 (12.78, 14.65) 834 (13.86) 14.03 (13.11, 15.00)
Diabetes 351 (5.86) 6.23 (5.60, 6.92) 357 (5.93) 6.37 (5.74, 7.07)
Chronic fever 378 (6.31) 5.49 (4.91, 6.15) 361 (6.00) 5.20 (4.62, 5.83)
Others 1,722 (28.76) 28.74 (27.53, 29.99) 1,744 (28.98) 29.16 (27.94, 30.41)
Type of healthcare received    
Inpatient care 521 (8.70) 9.40 (8.60, 10.20) 518 (8.61) 9.40 (8.60, 10.20)
Outpatient care 5,466 (91.30) 90.60 (89.80, 91.40) 5,500 (91.39) 90.60 (89.80, 91.40)
Types of health facilities    
Public facilities 1,024 (17.10) 19.70 (18.70, 20.80) 999 (16.60) 19.2 (18.20, 20.30)
Private facilities 3,937 (65.76) 75.90 (74.70, 77.00) 3,970 (65.97) 76.4 (75.20, 77.50)
Others 1,026 (17.14) 4.40 (3.80, 4.90) 1,049 (17.43) 4.4 (3.90, 5.00)
Waiting times for treatment    
<30 minutes 5017 (83.80) 81.30 (80.21, 82.34) 5026 (83.52) 80.93 (79.84, 81.97)
>30 minutes 970 (16.20) 18.70 (17.66, 19.79) 992 (16.48) 19.07 (18.03, 20.16)
Consulted provider location    
Rural based 2,719 (52.42) 52.42 (51.06, 53.78) 2,744 (52.79) 52.79 (51.43, 54.15)
Urban based 2,468 (47.58) 47.58 (46.22, 48.94) 2,454 (47.21) 47.21 (45.85, 48.57)
Overall 5,987 (49.87) 86.64 (85.75, 87.48) 6,018 (50.13) 86.34 (85.45, 87.19)

Distribution of health care utilisation (HCU)

The distribution of HCU due to chronic diseases by gender is presented in Table 1. Approximately overall 86% of patients utilised health care services in the last 30 days before the survey. 14% patients did not receive any healthcare services (Fig 3). The utilisation of health care reduced as patients aged. For instance, approximately one-third of the patients aged 18–35 years sought health care, which fell to around 5% among patients aged 65 years or more. Approximately 50% of married patients received any type of health care services (49.55% for males and 52.58% for females), which was among single participants. A significant difference in the prevalence of HCU was found between employed males (53.2%; 95% CI: 51.80, 54.50) and female patients (7.81%, 95% CI: 7.11, 8.58). However, approximately 92% of unemployed female patients utilised health care compared to their unemployed male counterparts (47%). Patients who experienced gastric/ulcer sought health care most among both male (16.04%, 95% CI: 15.07, 17.06) and female respondents (15.78% [95% CI: 14.82, 16.80]), while chronic fever was found to be the lowest health care seeking disease for both genders.

Fig 3. Percentage of not seeking any treatment.

Fig 3

The majority of patients’ highest rate of HCU was observed among those receiving outpatient care compared to that of inpatient care (90.60% vs. 9.40% for both genders). Health care utilisation was lower among those who had to wait more than 30 minutes for treatment than those who had to wait <30 minutes in both genders (81.30% vs. 18.7% for males; 80.93% vs. 18.03% for females). The HCU was highest among those who received care from private facilities than public facilities in both male (75.90% [95% CI: 74.70, 77.00] vs. 19.70% [95% CI: 18.70, 20.80]) and female patients (76.4% [95% CI: 75.20, 77.50] vs. 19.2% [95% CI: 18.20, 20.30]).

Correlations of chronic disease-specific and gendered HCU

Table 2 presents the detail results of regression analysis using eight disease-specific different models (Model 1 to Model 8). In the final model (Model 8), patients who were diagnosed with chronic heart disease, diabetes, gastric/ulcer and chronic fever had a significant association with HCU for both genders (all p < 0.05).

Table 2. Association between chronic disease-specific health care utilisation and related factors, by gender.

Chronic diseases or conditions Model-1 Model-2 Model-3 Model-4
Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value
For male patients
    Chronic heart disease 2.25 (1.53–3.31) <0.001 2.22 (1.51–3.27) <0.001 2.23 (1.52–3.27) <0.001 2.23 (1.52–3.28) <0.001
    Respiratory diseases/Asthma/Bronchitis 1.36 (1.03–1.80) 0.030 1.40 (1.06–1.84) 0.019 1.40 (1.06–1.85) 0.018 1.40 (1.06–1.85) 0.018
    Gastric/ulcer 0.75 (0.60–0.93) 0.009 0.77 (0.62–0.96) 0.018 0.77 (0.62–0.95) 0.017 0.77 (0.62–0.95) 0.017
    Blood pressure 1.11 (0.82–1.51) 0.490 1.14 (0.84–1.54) 0.400 1.15 (0.85–1.55) 0.381 1.15 (0.85–1.56) 0.367
    Arthritis/Rheumatism 1.00 (0.78–1.28) 1.000 1.04 (0.81–1.33) 0.749 1.04 (0.81–1.33) 0.749 1.04 (0.82–1.33) 0.746
    Diabetes 1.79 (1.19–2.69) 0.006 1.81 (1.20–2.74) 0.004 1.82 (1.21–2.74) 0.004 1.82 (1.21–2.74) 0.004
    Chronic fever 0.47 (0.36–0.62) <0.001 0.49 (0.38–0.65) <0.001 0.50 (0.38–0.65) <0.001 0.50 (0.38–0.65) <0.001
    Others (= reference group) 1.00 1.00 1.00 1.00
For female patients
    Chronic heart disease 1.45 (1.03–2.06) 0.034 1.43 (1.01–2.03) 0.042 1.43 (1.01–2.03) 0.043 1.43 (1.01–2.03) 0.042
    Respiratory diseases/Asthma/Bronchitis 1.16 (0.89–1.51) 0.267 1.19 (0.91–1.55) 0.196 1.19 (0.91–1.55) 0.197 1.19 (0.91–1.55) 0.194
    Gastric/ulcer 0.74 (0.60–0.92) 0.007 0.77 (0.62–0.95) 0.017 0.77 (0.62–0.96) 0.019 0.77 (0.62–0.96) 0.019
    Blood pressure 0.93 (0.70–1.23) 0.587 0.96 (0.72–1.27) 0.771 0.97 (0.73–1.28) 0.807 0.96 (0.73–1.28) 0.801
    Arthritis/Rheumatism 1.05 (0.82–1.34) 0.702 1.10 (0.86–1.41) 0.458 1.10 (0.86–1.41) 0.450 1.10 (0.86–1.41) 0.459
    Diabetes 1.92 (1.26–2.94) 0.002 1.94 (1.27–2.96) 0.002 1.95 (1.28–2.98) 0.002 1.95 (1.27–2.97) 0.002
    Chronic fever 0.45 (0.34–0.59) <0.001 0.45 (0.34–0.60) <0.001 0.46 (0.35–0.60) <0.001 0.46 (0.35–0.61) <0.001
    Others (= reference group) 1.00 1.00 1.00 1.00
Chronic diseases or conditions Model-5 Model-6 Model-7 Model-8
Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value
For male patients
    Chronic heart disease 2.22 (1.51–3.27) <0.001 2.22 (1.51–3.27) <0.001 2.22 (1.51–3.26) <0.001 2.22 (1.50–3.26) <0.001
    Respiratory diseases/Asthma/Bronchitis 1.40 (1.06–1.85) 0.018 1.40 (1.06–1.85) 0.018 1.40 (1.06–1.85) 0.018 1.40 (1.06–1.85) 0.018
    Gastric/ulcer 0.77 (0.62–0.96) 0.017 0.77 (0.62–0.95) 0.017 0.77 (0.62–0.98) 0.017 0.77 (0.62–0.95) 0.017
    Blood pressure 1.15 (0.85–1.56) 0.368 1.15 (0.85–1.56) 0.366 1.15 (0.85–1.56) 0.373 1.15 (0.85–1.56) 0.372
    Arthritis/Rheumatism 1.04 (0.81–1.33) 0.753 1.04 (0.81–1.33) 0.752 1.04 (0.81–1.32) 0.775 1.04 (0.81–1.32) 0.777
    Diabetes 1.82 (1.21–2.74) 0.004 1.82 (1.21–2.74) 0.004 1.82 (1.21–2.75) 0.004 1.82 (1.21–2.74) 0.004
    Chronic fever 0.49 (0.38–0.65) <0.001 0.49 (0.38–0.65) <0.001 0.49 (0.38–0.65) <0.001 0.49 (0.38–0.65) <0.001
    Others (= reference group) 1.00 1.00 1.00 1.00
For female patients
    Chronic heart disease 1.43 (1.01–2.02) 0.045 1.43 (1.01–2.03) 0.042 1.44 (1.02–2.04) 0.040 1.44 (1.02–2.04) 0.041
    Respiratory diseases/Asthma/Bronchitis 1.19 (0.91–1.55) 0.198 1.19 (0.92–1.56) 0.188 1.20 (0.92–1.56) 0.183 1.20 (0.92–1.56) 0.179
    Gastric/ulcer 0.77 (0.62–0.96) 0.021 0.78 (0.63–0.97) 0.024 0.78 (0.63–0.97) 0.025 0.78 (0.63–0.97) 0.026
    Blood pressure 0.96 (0.73–1.28) 0.795 0.97 (0.73–1.28) 0.819 0.97 (0.73–1.29) 0.839 0.97 (0.74–1.29) 0.860
    Arthritis/Rheumatism 1.09 (0.85–1.40) 0.486 1.10 (0.86–1.41) 0.458 1.10 (0.86–1.41) 0.451 1.10 (0.86–1.41) 0.444
    Diabetes 1.94 (1.27–2.97) 0.002 1.96 (1.28–3.00) 0.002 1.96 (1.28–3.00) 0.002 1.97 (1.29–3.01) 0.002
    Chronic fever 0.46 (0.35–0.61) <0.001 0.46 (0.35–0.61) <0.001 0.46 (0.35–0.61) <0.001 0.46 (0.35–0.62) <0.001
    Others (= reference group) 1.00 1.00 1.00 1.00

Note: Model 1: Chronic illness or conditions; Model 2: Adjusted for Model-1 + type of health care; Model 3: adjusted for Model 2+ age, Model 4: adjusted for Model 3+ educational background; Model 5: adjusted for Model 4 + religion status; Model 6: adjusted for Model 5 + marital status; Model 7: adjusted for Model 6 + employment status; Model 8: adjusted for Model 7 + type of health care facilities, consultation provider’s location, number of chronic comorbid conditions and waiting times. In the unadjusted model (results not shown in Table 2), all selected variables were significant at 5% or less risk level.

We found that patients with chronic heart disease had significantly higher HCU compared to patients with other chronic diseases. However, the magnitude of association was higher among male patients (OR = 2.22; 95% CI:1.51–3.26; p<0.001) than their female counterparts (OR = 1.44; 1.02–2.04; p = 0.041). Similarly, diabetes patients reported significant HCU in both genders (OR = 1.82; 1.21–2.74; p = 0.004 for male patients and OR = 1.97, 1.28–3.00; p = 0.002 for female patients). The magnitude of HCU also depended on the severity of diseases. For example, patients with gastric/ulcer had significantly lower HCU [23% for male patients, (OR = 0.77; 0.62–0.95; p = 0.017) or 22% for female patients, (OR = 0.78; 0.63–0.97; p = 0.026)] compared to patients diagnosed with other diseases. A similar association was observed for patients diagnosed with chronic fever (for male patients, OR = 0.49; 0.38–0.65; p = 0.026 or female patients, OR = 0.46; 0.35–0.61; p<0.001). In addition, these associations were consistent with sensitivity analysis testing robustness of results using the bootstrapping approach by resampling observations with 10,000 replications (Table 3).

Table 3. Sensitivity analysis testing robustness of results using the bootstrapping approach by resampling observations.

Chronic diseases or conditions Observed Odds Ratio Bootstrap Std. Err. Normal-based 95% confidence interval P-value
For male patients
    Chronic heart disease 2.21 0.44 1.49 3.29 <0.001
    Respiratory diseases/Asthma/Bronchitis 1.40 0.20 1.05 1.86 0.020
    Gastric/ulcer 0.76 0.08 0.61 0.95 0.018
    Blood pressure 1.14 0.18 0.84 1.56 0.378
    Arthritis/Rheumatism 1.03 0.13 0.8 1.32 0.778
    Diabetes 1.82 0.39 1.19 2.78 0.006
    Chronic fever 0.49 0.06 0.37 0.64 <0.001
    Other chronic diseases (= reference group) 1.00        
Number of observations 5,987 patients
    Replications 10,000 times
Wald chi2 (p-value) 112.15 (p<0.001)
Chronic diseases or conditions Observed Odds Ratio Bootstrap Std. Err. Normal based 95% confidence interval P-value
For female patients
    Chronic heart disease 1.44 0.27 1.00 2.07 0.048
    Respiratory diseases/Asthma/Bronchitis 1.20 0.16 0.92 1.56 0.185
    Gastric/ulcer 0.78 0.09 0.62 0.97 0.028
    Blood pressure 0.97 0.14 0.73 1.30 0.842
    Arthritis/Rheumatism 1.10 0.14 0.86 1.41 0.452
    Diabetes 1.96 0.43 1.27 3.02 0.002
    Chronic fever 0.46 0.07 0.35 0.61 <0.001
    Other chronic diseases (= reference group) 1.00      
Number of observations 6,018 patients
    Replications 10,000 times
Wald chi2 (p-value) 109.61 (p<0.001)

Discussion

This study examined the disease-stratified and gender- differentiated HCU in Bangladesh among patients with chronic diseases. The major chronic diseases reported were chronic heart diseases, respiratory diseases/asthma/bronchitis, gastric/ulcer, blood pressure, arthritis/rheumatism, diabetes, and chronic fever. They were found alike among males and females. However, the magnitude of seeking healthcare services due to these chronic conditions varied across the types of chronic diseases and gender. For example, participants with chronic heart disease, diabetes, and respiratory diseases reported highest HCU in both genders, while chronic fever had the lowest HCU.

The seeking of healthcare services may be influenced by disease severity and various demographic and socioeconomic factors. The burden of chronic diseases combined with frequent acute illness episodes increases the risk of high levels of long-term adverse events (e.g., comorbidity, mortality and disability) compared to other diseases [5, 8, 11, 29]. Patients with chronic illness also have a greater risk of being diagnosed with other associated comorbidities, which increase utilisation of healthcare services [30]. Chronic diseases damage lives and adversely affect the quality of life and ultimate disability, which increases the HCU among affected patients [31]. Long-lasting chronic conditions result in a continuation of treatment and care, which increases the use of healthcare resources (e.g., specialist consultations, diagnostic, medicines) [32, 33]. The severity of the chronic illness (i.e. heart disease, diabetes) leads to more health care service utilisation, increasing the economic burden compared to the other diseases [16].

Taking a gendered perspective to disease-specific chronic illnesses shows the magnitude of HCU differs significantly between males and females. For instance, male patients with chronic heart disease utilised healthcare services at a rate more than two times higher compared to female patients. This trend was also consistent for respiratory diseases and blood pressure, although females slightly utilised more healthcare services for diabetes. Generally, the lower utilisation of healthcare among females in Bangladesh compared to males mainly depends on who is making the HCU decision, financial capability and accessibility power, knowledge and awareness [3440]. One study reported that Bangladeshi males are more unwilling to adhere to and continue treatment for chronic heart disease compared to females [41]. These practices among males may lead to the recurrence of chronic heart diseases like hypertension and trigger more HCU for heart diseases. Another study in Bangladesh showed that the male-headed family heritage leads to demotivated women’s decisions about their healthcare even when there is agreement from senior family members, especially husbands and/or mothers-in-law [42]. This supports the finding of another study [43] that showed that 37% of Bangladesh women had no decision-making power about their healthcare utilisation. This was even more extreme at 55.6% as reported in India [44]. However, studies in Spain and the USA reported that older female were more likely to use medical practitioners, outpatient health services and medications than men [45, 46]. In the USA, women face a higher rate of disability and poor health conditions and are more unlikely to receive the prescribed drugs due to cost [46, 47]. Besides, males have to pay much more for HCU due to the higher rate of obesity and cardiovascular diseases [48]. In addition, the location of healthcare service providers, disproportionate population density, and education are crucial factors for seeking healthcare [4951]. Access to money for their own healthcare is an influential factor for women’s HCU. A study expressed that only 14% of married women can decide on their health care in Ethiopia, while only 38% can use money independently for their healthcare [35]. Studies in India [52, 53] reported high (about 50%) gender disparity in healthcare expenditure which increased for older patients and also women’s healthcare needs are regularly and often neglected or have less priority in households.

In the UK, women who get support from their husbands in decision making had a higher odds of HCU and it increased in urban areas compared to rural areas [27]. Another study in the UK showed that males are 32% less likely to have a primary healthcare consultation than females [54]. The cultural consequences exposed that the HCU may depend on disease severity and magnitude of health burden, especially for women. It is not necessarily true that the males are more conscious and knowledge enriched about the chronic diseases in Bangladesh that may influence the overall lower HCU.

Nevertheless, during recent years, remarkable success and changes have occurred in maternal HCU in Bangladesh. However, there are still low HCU and women’s autonomy practices, particularly in rural areas, and for women with lower education and socioeconomic status [40, 55, 56]. The above evidence indicates that being a South Asian country, there exists a significant gap in opportunities and privileges for women in Bangladeshi families. Social supports, risk-pooling mechanisms, early risk detections and community-based awareness programs may contribute to achieving universal health coverage for women over time.

The current study utilised the most recent household income and expenditure survey data which is nationally representative of the Bangladeshi population. These national-level data make the study findings more precise and reliable. However, there are still some limitations regarding this study which the authors acknowledge. For instance, self-reported data of the key variables of interest were used, and findings should be interpreted cautiously. In addition, the survey data consist of information about self-reported illness, utilisation of healthcare services, and expenditure that might be affected by recall bias, although only information from the last 30 days was considered, which reduces the chances of potential recall bias due to the short recall period. Cross-sectional studies are normally a type of observational study design rather than longitudinal design; therefore, it is difficult to determine any causal relationships among variables. Moreover, in the HIES data, a high number of people reported “other” chronic disease without specifying the type of disease they suffered from. Therefore, we had to consider the most prevalent chronic diseases they suffered from.

Conclusions

The present study focused on chronic disease-stratified and gender-based HCU in Bangladesh. HCU due to chronic illness is significantly higher among the male population than females. The circumstances demand that affordable and accessible healthcare services are urgently needed for women, especially in rural areas. The government and other related organisations should focus on improved healthcare system planning, healthcare service quality improvement strategies and special healthcare benefits for disadvantaged individuals, especially women. Social supports, risk-pooling mechanisms, early risk detection and community-based awareness development may contribute to progressing universal health coverage. In addition, resource allocation, capacity building, technology enabled health system can be considered to cope with the new challenges during this current pandemic and post-COVID healthcare management. Further rigorous research should be conducted to understand the core factors, exchange and enhance the beliefs and knowledge about chronic diseases and their gendered treatment in Bangladesh.

Acknowledgments

This research was carried out using the 2016–2017 Bangladesh Household Income and Expenditure Survey. We would like to thank the HIES program for providing access to the data utilised in this research. We would also like to gratefully acknowledge the study’s participants, reviewers and the academic editors of our manuscript.

Data Availability

Bangladesh Household Income and Expenditure Survey (HIES) is conducted by the Bangladesh Bureau of Statistics (BBS) with technical and financial support from the World Bank. This research was carried out using the 2016-2017 Bangladesh Household Income and Expenditure Survey. However, the BBS imposed legal restrictions that prevent the sharing of data publicly. Data can be shared upon request to the corresponding author with the permission of the BBS (Director General, Bangladesh Bureau of Statistics, dg@bbs.gov.bd, +88-02-5500-7056, www.bbs.gov.bd).

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.WHO. Noncommunicable diseases progress monitor 2020. Geneva: World heald Organization; 2020. Available: https://www.who.int/publications/i/item/9789240000490 [Google Scholar]
  • 2.WHO. Noncommunicable diseases. In: Key facts [Internet]. 2021. Available: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases [Google Scholar]
  • 3.Vos T, Lim SS, Abbafati C, Machado DB, Cislaghi B, Salman OM, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396 (10258):1204–1222. doi: 10.1016/S0140-6736(20)30925-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.United Nations. Sustainable Development Goals. In: The Sustainable Development Agenda [Internet]. 2017. [cited 26 Dec 2021]. Available: https://www.un.org/sustainabledevelopment/health/ [Google Scholar]
  • 5.Bleich SN, Koehlmoos TLP, Rashid M, Peters DH, Anderson G. Noncommunicable chronic disease in Bangladesh: Overview of existing programs and priorities going forward. Health Policy. 2011;100(2–3):282–9. doi: 10.1016/j.healthpol.2010.09.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Biswas T, Islam MS, Linton N, Rawal LB. Socio-economic inequality of chronic non-communicable diseases in Bangladesh. PLoS One. 2016;11 (11):e0167140. doi: 10.1371/journal.pone.0167140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. 2009. World Health Organization. https://apps.who.int/iris/handle/10665/44203 [Google Scholar]
  • 8.Bangladesh Society of Medicine, World Health Organization, Directorate General of Health Services, Ministry of health & Family Welfare, Bangladesh. Non-Communicable Disease Risk Factor Survey Bangladesh 2010. 2011. https://www.who.int/docs/default-source/searo/bangladesh/pdf-reports/year-2007-2012/non-communicable-disease-risk-factor-survey-bangladesh-2010.pdf?sfvrsn=37e45e81_2 [Google Scholar]
  • 9.IHME. Bangladesh | Institute for Health Metrics and Evaluation. 2021. [Google Scholar]
  • 10.Al-Zubayer MA, Ahammed B, Sarder MA, Kundu S, Majumder UK, Islam SMS. Double and triple burden of non-communicable diseases and its determinants among adults in Bangladesh: Evidence from a recent demographic and health survey. Int J Clin Pract. 2021;75(10): e14613. doi: 10.1111/ijcp.14613 [DOI] [PubMed] [Google Scholar]
  • 11.Khan N, Rahman M, Mitra D, Afsana K. Prevalence of multimorbidity among Bangladeshi adult population: A nationwide cross-sectional study. BMJ Open. 2019;9(11):e030886. doi: 10.1136/bmjopen-2019-030886 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Khanam MA, Streatfield PK, Kabir ZN, Qiu C, Cornelius C, Wahlin Å. Prevalence and patterns of multimorbidity among elderly people in rural Bangladesh: A cross-sectional study. J Health Popul Nutr. 2011;29 (4): 406–14. doi: 10.3329/jhpn.v29i4.8458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Baker JL. Bangladesh—Dhaka: Improving living conditions for the urban Poor. 2007. World Bank. World Bank. https://openknowledge.worldbank.org/handle/10986/7686 License: CC BY 3.0 IGO.” [Google Scholar]
  • 14.World Health Organization. Bangladesh health system review. Vol. 5. No. 3. WHO Regional Office for the Western Pacific, 2015. https://apps.who.int/iris/bitstream/handle/10665/208214/9789290617051_eng.pdf [Google Scholar]
  • 15.Brinda EM, Kowal P, Attermann J, Enemark U. Health service use, out-of-pocket payments and catastrophic health expenditure among older people in India: The WHO study on global AGEing and adult health (SAGE). J Epidemiol Community Health. 2015;69 (5):489–94. doi: 10.1136/jech-2014-204960 [DOI] [PubMed] [Google Scholar]
  • 16.Sultana M, Mahumud RA, Sarker AR. Burden of chronic illness and associated disabilities in Bangladesh: Evidence from the Household Income and Expenditure Survey. Chronic Dis Transl Med. 2017;3(2): 112–122. doi: 10.1016/j.cdtm.2017.02.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.World Health Organization. Health and Gender equality: Policy Brief WHO/Europe | Gender. 2016. https://www.euro.who.int/__data/assets/pdf_file/0008/404495/SDG-5-policy-brief_2.pdf [Google Scholar]
  • 18.WHO. STRATEGY FOR INTEGRATING GENDER ANALYSIS AND ACTIONS INTO THE WORK OF WHO. 2008. [Google Scholar]
  • 19.Sen G, Östlin P, George A. Unequal, Unfair, Ineffective and Inefficient Gender Inequity in Health: Why it exists and how we can change it. Final Rep to WHO Comm Soc Determ Heal. 2007. https://eurohealth.ie/wp-content/uploads/2012/02/Unequal-Unfair-Ineffective-and-Inefficient-Gender-Inequity-in-Health.pdf [Google Scholar]
  • 20.Roy K, Chaudhuri A. Influence of socioeconomic status, wealth and financial empowerment on gender differences in health and healthcare utilization in later life: evidence from India. Soc Sci Med. 2008;66(9):1951–62. doi: 10.1016/j.socscimed.2008.01.015 [DOI] [PubMed] [Google Scholar]
  • 21.Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. Journal of Family Practice. 2000; 49(2): 147–152. [PubMed] [Google Scholar]
  • 22.Awasthi S, Srivastava NM, Pant S. Symptom-specific care-seeking behavior for sick neonates among urban poor in Lucknow, Northern India. Journal Perinatol, 2008; Suppl2:S69–75. doi: 10.1038/jp.2008.169 [DOI] [PubMed] [Google Scholar]
  • 23.BBS.Preliminary Report on Bangladesh Household Income andExpenditure Survey 2016–2017. Bangladesh Bureau of Statistics,Statistics Division, Ministry of Planning. Government of the People’sRepublic of Bangladesh; 2017. http://data.bbs.gov.bd/index.php/catalog/182 [Google Scholar]
  • 24.Sheikh N, Sarker AR, Sultana M, Mahumud RA, Ahmed S, Islam MT, et al. Disease ‑ specific distress healthcare financing and catastrophic out ‑ of ‑ pocket expenditure for hospitalization in Bangladesh. 2022; 21 (1); 1–16. doi: 10.1186/s12939-022-01712-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ahmed F, Oni FA, Sharafat Hossen S. Does gender inequality matter for access to and utilization of maternal healthcare services in Bangladesh? PLoS One. 2021;16(9): e0257388. doi: 10.1371/journal.pone.0257388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Imtiaz A, Khan NM, Hasan E, Johnson S, Nessa HT. Patients’ choice of healthcare providers and predictors of modern healthcare utilisation in Bangladesh: Household Income and Expenditure Survey (HIES) 2016–2017 (BBS). BMJ Open. 2021;11(12): e051434. doi: 10.1136/bmjopen-2021-051434 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ghose B, Feng D, Tang S, Yaya S, He Z, Udenigwe O, et al. Women’s decision-making autonomy and utilisation of maternal healthcare services: Results from the Bangladesh Demographic and Health Survey. BMJ Open. 2017;7(9):e017142. doi: 10.1136/bmjopen-2017-017142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hossain A, Alam MJ, Mydam J, Tareque M. Do the issues of religious minority and coastal climate crisis increase the burden of chronic illness in Bangladesh? BMC Public Health. 2022;22(1): 1–19. doi: 10.1186/s12889-022-12656-5 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kankeu HT, Saksena P, Xu K, Evans DB. The financial burden from non-communicable diseases in low- and middle-income countries: A literature review. Heal Res Policy Syst. 2021;19(1): 1–12. doi: 10.1186/1478-4505-11-31 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Parr JD, Lindeboom W, Khanam MA, Pérez Koehlmoos TL. Diagnosis of chronic conditions with modifiable lifestyle risk factors in selected urban and rural areas of Bangladesh and sociodemographic variability therein. BMC Health Serv Res. 2011;11(309): 1–9. doi: 10.1186/1472-6963-11-309 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wang H, Naghavi M, Allen C, Barber RM, Carter A, Casey DC, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053): 1459–1544. doi: 10.1016/S0140-6736(16)31012-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mofizul Islam M, Yen L, Valderas JM, McRae IS. Out-of-pocket expenditure by Australian seniors with chronic disease: The effect of specific diseases and morbidity clusters. BMC Public Health. 2014;14 (1008): 1–18. doi: 10.1186/1471-2458-14-1008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.De Carvalho Yokota RT, Van Der Heyden J, Johanna Nusselder W, Robine JM, Tafforeau J, Deboosere P, et al. Impact of chronic conditions and multimorbidity on the disability burden in the older population in Belgium. Journals Gerontol—Ser A Biol Sci Med Sci. 2016;71(7):903–9. doi: 10.1093/gerona/glv234 . [DOI] [PubMed] [Google Scholar]
  • 34.Osamor PE, Grady C. Women’s autonomy in health care decision-making in developing countries: A synthesis of the literature. International Journal of Women’s Health. 2016; 8(191): doi: 10.2147/IJWH.S105483 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Nigatu D, Gebremariam A, Abera M, Setegn T, Deribe K. Factors associated with women’s autonomy regarding maternal and child health care utilization in Bale Zone: A community based cross-sectional study. BMC Womens Health. 2014;14(79):1–9. doi: 10.1186/1472-6874-14-79 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mahumud RA, Alamgir NI, Hossain MT, Baruwa E, Sultana M, Gow J, et al. Women’s preferences for maternal healthcare services in Bangladesh: Evidence from a Discrete Choice Experiment. J Clin Med. 2019;8(2): 1–21. doi: 10.3390/jcm8020132 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Jacobs Bart, Ir Por, Bigdeli Maryam, Peter Leslie Annear Wim Van Damme. Addressing access barriers to health services: an analytical framework for selecting appropriate interventions in low-income Asian countries. Heal Policy Plan. 2012; 27(4):288–300. doi: 10.1093/heapol/czr038 [DOI] [PubMed] [Google Scholar]
  • 38.Ensor T, Cooper S. Overcoming barriers to health service access: Influencing the demand side. Health Policy and Planning. 2004; 19(2): 69–79. doi: 10.1093/heapol/czh009 . [DOI] [PubMed] [Google Scholar]
  • 39.Peters DH, Garg A, Bloom G, Walker DG, Brieger WR, Hafizur Rahman M. Poverty and access to health care in developing countries. Annals of the New York Academy of Sciences. 2008; 1136(1): 161–171. doi: 10.1196/annals.1425.011 [DOI] [PubMed] [Google Scholar]
  • 40.Khan MN, Mofizul Islam M. Women’s attitude towards wife-beating and its relationship with reproductive healthcare seeking behavior: A countrywide population survey in Bangladesh. PLoS One. 2018;13(6):e0198833. doi: 10.1371/journal.pone.0198833 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Khanam MA, Lindeboom W, Koehlmoos TLP, Alam DS, Niessen L, Milton AH. Hypertension: Adherence to treatment in rural Bangladesh—findings from a population-based study. Glob Health Action. 2014;7(25028):1–9. doi: 10.3402/gha.v7.25028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Haque SE, Rahman M, Mostofa MG, Zahan MS. Reproductive Health Care Utilization among Young Mothers in Bangladesh: Does Autonomy Matter? Women’s Heal Issues. 2012;22(2):e171–80. doi: 10.1016/j.whi.2011.08.004 . [DOI] [PubMed] [Google Scholar]
  • 43.Rahman MM, Mostofa MG, Hoque MA. Women’s household decision-making autonomy and contraceptive behavior among Bangladeshi women. Sex Reprod Healthc. 2014;5(1): 9–15. doi: 10.1016/j.srhc.2013.12.003 . [DOI] [PubMed] [Google Scholar]
  • 44.Mistry R, Galal O, Lu M. Women’s autonomy and pregnancy care in rural India: A contextual analysis. Soc Sci Med. 2009;69(6): 926–33. doi: 10.1016/j.socscimed.2009.07.008 . [DOI] [PubMed] [Google Scholar]
  • 45.Redondo-Sendino Á, Guallar-Castillón P, Banegas JR, Rodríguez-Artalejo F. Gender differences in the utilization of health-care services among the older adult population of Spain. BMC Public Health. 2006;6(155): 1–9. doi: 10.1186/1471-2458-6-155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.National Academy of Science NAS. Health-Care Utilization as a Proxy in Disability Determination. Heal Util as a Proxy Disabil Determ. 2018. doi: 10.17226/24969 [DOI] [PubMed] [Google Scholar]
  • 47.National Center for Health Statistics. Health, United States, 2016: With chartbook on long-term trends in health. Dep Heal Hum Serv. 2017. Report No: 2017–1232. [PubMed] [Google Scholar]
  • 48.Salganicoff A, Ranji U, Beamesderfer A, Kurani N. Women and Health Care in the Early Years of the ACA: Key Findings from the 2013 Kaiser Women’s Health Survey. 2014. https://www.kff.org/womens-health-policy/report/women-and-health-care-in-the-early-years-of-the-aca-key-findings-from-the-2013-kaiser-womens-health-survey/ [Google Scholar]
  • 49.Nesbitt RC, Lohela TJ, Soremekun S, Vesel L, Manu A, Okyere E, et al. The influence of distance and quality of care on place of delivery in rural Ghana. Sci Rep. 2016;6(30291):1–8. doi: 10.1038/srep30291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Sato R, Rohr J, Huber-Krum S, Esmer Y, Okçuoğlu BA, Karadon D, et al. Effect of distance to health facilities and access to contraceptive services among urban Turkish women. Eur J Contracept Reprod Heal Care. 2021;26(5):374–382. doi: 10.1080/13625187.2021.1906412 [DOI] [PubMed] [Google Scholar]
  • 51.Elewonibi B, Sato R, Manongi R, Msuya S, Shah I, Canning D. The distance-quality trade-off in women’s choice of family planning provider in North Eastern Tanzania. BMJ Glob Heal. 2020;5(2):e002149. doi: 10.1136/bmjgh-2019-002149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Mondal B, Dubey JD. Gender discrimination in health-care expenditure: An analysis across the age-groups with special focus on the elderly. Soc Sci Med. 2020;258(113089):1–11. doi: 10.1016/j.socscimed.2020.113089 [DOI] [PubMed] [Google Scholar]
  • 53.Saikia N, Moradhvaj, Bora JK. Gender difference in health-care expenditure: Evidence from India human development survey. PLoS One. 2016;11(7):e0158332. doi: 10.1371/journal.pone.0158332 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wang Y, Hunt K, Nazareth I, Freemantle N, Petersen I. Do men consult less than women? An analysis of routinely collected UK general practice data. BMJ Open. 2013;3(8):e003320. doi: 10.1136/bmjopen-2013-003320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Pulok MH, Sabah MNU, Uddin J, Enemark U. Progress in the utilization of antenatal and delivery care services in Bangladesh: Where does the equity gap lie? BMC Pregnancy Childbirth. 2016;16(1):1–16. doi: 10.1186/s12884-016-0970-4 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.National Institute of Population Research and Training (NIPORT), Mitra and Associates, and ICF International. 2016. Bangladesh Demographic and Health Survey 2014. Dhaka, Bangladesh, and Rockville, Maryland, USA: NIPORT, Mitra and Associates, and ICF International. [Google Scholar]

Decision Letter 0

Hamid Reza Baradaran

15 Jul 2022

PONE-D-22-15927The emerging burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among adult patients in BangladeshPLOS ONE

Dear Dr. Mahumud,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Thanks for  conducting this  study  ; Please consider some  important points  in revised version

1- House Hold Survey should be  more clear  in method section

2- Please elaborate  employed analysis  for readers

==============================

Please submit your revised manuscript by Aug 29 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Hamid Reza Baradaran, M.D., Ph.D.,

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

Additional Editor Comments:

Thanks for conducting this study ; Please consider some important points in revised version

1- House Hold Survey should be more clear in method section

2- Please elaborate employed analysis for readers

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Title: OK however a shorter title is desirable.

abstract: OK; however, a number of revisions may be necessary in case of revision of the following sections as requested afterward.

introduction: OK

material & method: Please notice the the following comments:

- Please address the matter of ethical issues and their confirmation in this section as well.

- please define the inclusion and exclusion criteria in more detail. for instance, it is necessary to clarify if more than 1 person were permitted o be recruited for study in each household. this is very important for estimating the variance of the proposed measures.

- I think it is necessary to show the reliability of the responses to the utilization question too.

- Please state how disease history variables were measured in each individuals explicitly. this will affect the justification of the next section (results).

- Considering the type of sampling please define how variables were weighted for the analysis. because of considering all members in each household for the study, there is a considerable amount of intra-class correlation which will affect the precision of the estimations.

- I think this level of significance is very conservative to recruit variables in the next stage model. (line 8, page 7)

- In the table 1, I think it is better to show this table according to utilization instead of gender. in this case it will be more sensible to see the association of the each variable and utilization separately.

Reviewer #2: Introduction:

- In the introduction, there is no evidence that the burden of chronic diseases in Bangladesh is increasing in the last decade. These diseases are almost age-related. The introduction does not mention the prevalence of chronic diseases at different ages or age-adjusted rates.

- In the introduction, it should be noted whether the population of Bangladesh is aging, which has caused concern?

- The importance of conducting this research is not clear.

Methods:

- Data and information in the study is related to 2016-2017. My question is how to deal with the emerging burden of disease? In my opinion, if the data were used from a cohort study or from two consecutive censuses, the results would be more accurate and comprehensive.

- Where can I find a list of chronic diseases? For example, in this section, there is no mentioned to kidney diseases.

- The method of adjusting variables in models is confusing and unclear.

- Was regression or logistic regression used in this study?

- The method of initial selection of variables to enter the model is not clear.

- The level of statistical significance should be less than 5% and not equal to 5%.

Results:

- Percentages should be written in numbers and not in letters.

- The title of the article states that the study was conducted on adults, but the results indicate that almost 42% of people are young. This is a contradiction.

- If one-third of patients had no formal education, how do they name their disease? The respondent is not known in this study.

- In this section was stated that “The utilisation of health care reduced as patients aged”. Has a statistical test been performed?

- In the division of chronic diseases (see Table 1), there is a group called "others", which is about 28% of patients. I think this group should be divided into more specific subgroups.

Final:

- This manuscript does not have enough coherence. The title of the study is not in line with the final results and conclusions. Therefore, it cannot be published.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Babak Eshrati

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 May 2;18(5):e0284117. doi: 10.1371/journal.pone.0284117.r002

Author response to Decision Letter 0


20 Sep 2022

Date: 21 Aug, 2022

Prof. Hamid Reza Baradaran

Academic Editor

PLOS ONE

Response to Reviewers’ comments on Manuscript Number: PONE-D-22-15927

The revised title of the manuscript: "The burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among patients in Bangladesh".

Dear Prof. Baradaran

Thank you for the opportunity to revise our manuscript. We found the reviewers' comments and feedback very helpful in improving the manuscript and we have revised the manuscript accordingly. Please find below our point–by–point responses to each of the reviewers' comments. Two versions of our paper – one clean copy, and one with marked-up copy showing the changes made – are submitted.

We look forward to hearing from you.

Yours sincerely,

Dr Rashidul Alam Mahumud (corresponding author)

On behalf of all co-authors

Response to the Editor Comments

Additional Editor Comments:

Thanks for conducting this study; Please consider some important points in revised version

1- Household survey should be more clear in method section

2- Please elaborate employed analysis for readers

Authors’ response: Thank you very much for your comments and suggestions regarding the manuscript. We have updated the sections in the revised manuscript.

Response to Reviewer #1

1. Title: OK however a shorter title is desirable.

Author’s response: We have revised the title of this manuscript. Currently it reads, “The burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among patients in Bangladesh”. Please see the revised title.

2. abstract: OK; however, a number of revisions may be necessary in case of revision of the following sections as requested afterward.

Author’s response: Thanks for your comment. The entire manuscript has been revised and updated to incorporate the reviewer’s comments. Please see the revised manuscript.

3. Introduction: OK

Author’s response: Thank you.

4. Material & method: Please notice the following comments: Please address the matter of ethical issues and their confirmation in this section as well.

Author’s response: Thank you for the suggestion. We have added sub-section about ethical issues in the method section. Please see the revised manuscript (page 9, lines 6-9).

5. Please define the inclusion and exclusion criteria in more detail. For instance, it is necessary to clarify if more than 1 person were permitted to be recruited for study in each household. this is very important for estimating the variance of the proposed measures.

Author’s response: This study used the nationally representative Household Income and Expenditure Survey, 2016-17 data.

The participants for the present analysis were selected based on the HIES 2016-17 survey protocol and the following inclusion criteria: i) an individual who had suffered from any chronic disease for the last 12 months or more, ii) an individual who suffered from any chronic diseases or chronic conditions in the last 30 days, and iii) individual who received any treatment due to chronic illness in the last 30 days. This study used individual-level data to explore who has been exposed to any chronic disease. Please see page 6 (lines 19-24).

6. I think it is necessary to show the reliability of the responses to the utilisation question too.

Authors’ response: We analysed secondary data from the nationally representative Household Income and Expenditure Survey (HIES 2016-17). Bangladesh Bureau of Statistics (BBS) has already validated the study settings and tested the reliability of the data. The details of the study settings, questionnaire, and quality control measures have been described in the HIES 2016-17 report summary1. The HIES 2016-17 survey was based on an established protocol1. The HIES is a cross-sectional survey conducted by the BBS in Bangladesh every five (5) years since 19731; throughout the period of implementation, the HIES tools have been thoroughly reviewed to address the validity and reliability of the results.

In line with the objective of HIES survey, the HIES 2016-17 survey collected information under nine modules: 1) household information, 2) education, 3) health: illnesses and injuries, 4) economic activities and wage employment, 5) non-agricultural enterprises, 6) housing, 7) agriculture, 8) other assets and income, and 9) consumption. However, the objective of the current article was to investigate disease-stratified healthcare utilisation (HCU) among Bangladesh patients with chronic diseases from a gender perspective. Therefore, we only use the indicators pertaining to chronic disease and health service utilisation along with socio-demographic characterises of the participants.

The HIES datasets are widely accepted and validated to produce scientific evidence. It is also used for monitoring the progress of poverty reduction and the Sustainable Development Goals (SDGs) indicators in Bangladesh. Please see some recent existing publications using the HIES data sets.

1. Ahmed et al. (2022). Assessing the incidence of catastrophic health expenditure and impoverishment from out-of-pocket payments and their determinants in Bangladesh: evidence from the nationwide Household Income and Expenditure Survey 2016. International Health; 14: 84–96. https://doi.org/10.1093/inthealth/ihab015

2. Rahman et al. (2022). Financial risk protection in health care in Bangladesh in the era of Universal Health Coverage. PLoS ONE 17(6): e0269113. https://doi.org/10.1371/journal.pone.0269113

3. Hossain et al. (2022). Do the issues of religious minority and coastal climate crisis increase the burden of chronic illness in Bangladesh? BMC Public Health 22(270) https://doi.org/10.1186/s12889-022-12656-5

4. Mitu et al. (2022). Spatial Differences in Diet Quality and Economic Vulnerability to Food Insecurity in Bangladesh: Results from the 2016 Household Income and Expenditure Survey. Sustainability 2022, 14(5643). https://doi.org/10.3390/su14095643

5. Mishra et al. (2015). Abiotic stress and its impact on production efficiency: The case of rice farming in Bangladesh. Agriculture, Ecosystems and Environment 199; 146–153. http://dx.doi.org/10.1016/j.agee.2014.09.006

This study does not require any additional reliability test for healthcare utilisation questions. Please see more detail information in the published HIES 2016-17 report. Please see page 6 (lines 1-22).

7. Please state how disease history variables were measured in each individual explicitly. this will affect the justification of the next section (results).

Author’s response: Thank you for your insightful feedback.

Our study population was selected based on inclusion criteria: i) an individual who had suffered from any chronic disease for the last 12 months or more, ii) individual who received any treatment due to chronic illness in the last 30 days, and iii) individual who received any treatment due to chronic illness in the last 30 days.

Participants responded based on their disease diagnosis, experiences, symptoms of illness and course of treatment. All health-related information was self-reported in the HIES survey. For conducting the analysis, we used chronic disease-related questions that were included in Module-3: Health (Illnesses and Injuries) of the primary survey. For example, while collecting chronic disease-related information, the enumerators were instructed to ask the respondents, "Have you suffered from any chronic illness/disability in the last 12 months or more?" (if yes); then, participants were asked a second question “What chronic illness/disability are you suffering from?” with response options: 1) chronic fever, 2) Injuries/disability, 3) Chronic heart disease, 4) Respiratory Diseases/ Asthma/Bronchitis, 5) Diarrhoea/dysentery, 6) Gastric/ulcer, 7) Blood pressure, 8) Arthritis/Rheumatism, 9) Skin problem, 10) Diabetes, 11) Cancer, 12) Kidney diseases, 13) Liver Diseases, 14) Mental Health, 15) Paralysis, 16) Ear/ENT problem, 17) Eye problem, or 18 other (specify).

8. Considering the type of sampling please define how variables were weighted for the analysis. because of considering all members in each household for the study, there is a considerable amount of intra-class correlation which will affect the precision of the estimations.

Author’s response: Thanks for pointing this out. We agree with you. In our analysis, we investigated individual-level data to estimate disease-specific healthcare utilisation due to chronic illness by gender prospective. However, we have followed standard ‘svy’ prefix command to address sampling weights. In addition, before running the final model, we checked for multicollinearity using Variance inflation factor (VIF) among the selected variables, no serious issues multicollinearity were found among the variables (all variables with VIF <5.00). The model was tested for sensitivity using the bootstrapping approach by resampling observations with 10,000 replications. Please page 8-10 (new Table 3).

9. I think this level of significance is very conservative to recruit variables in the next stage model. (Line 8, page 7)

Author’s response: We followed the standard procedure of independent variable selection for the model with the widely used cut-off of p ≤ 0.05 in the unadjusted model [1–5].

10. In the table 1, I think it is better to show this table according to utilisation instead of gender. in this case it will be more sensible to see the association of each variable and utilisation separately.

Author’s response: Thank you. Our study objective was to investigate disease-stratified healthcare utilisation (HCU) among patients with chronic diseases in Bangladesh from a gender perspective. Therefore, Table 1 has been formatted to report healthcare utilisations by gender. All analyses were stratified by gender according to the study objective. Please see Table 1.

Response to the Reviewer #2

1. Introduction: In the introduction, there is no evidence that the burden of chronic diseases in Bangladesh is increasing in the last decade. These diseases are almost age-related. The introduction does not mention the prevalence of chronic diseases at different ages or age-adjusted rates.

Author’s response: Thank you very much for your comment. We have updated the introduction part in the revised manuscript. Please check the revised manuscript. Please see page 4 and 5.

2. In the introduction, it should be noted whether the population of Bangladesh is aging, which has caused concern?

Author’s response: Basically, the analytical dataset of this study reveals that chronic diseases are not only significantly prevalent among the aged population but also among the young and young adults (Please see Table 1). Therefore, in general, the burden of chronic disease is not only a major concern for the aged but also the young and young adult population in Bangladesh. Please see page 4 and 5.

3. The importance of conducting this research is not clear.

Author’s response: The introduction has now been revised and the significance of the research has been incorporated in the manuscript. Please see the revised introduction section

This section now reads: “There are still gender disparities in decision-making, roles and rights at home, and self-esteem when it comes to empowering women, which limits their access to healthcare in developing countries [20-22]. This is also true for Bangladesh, where men are often viewed as the head of households, decision-makers and are usually in charge of household resources and who typically decide on the women’s health needs and where and when they should utilise healthcare services [20, 22]. To achieve SDG 5: Health and gender equality, it is imperative to ensure women have access to appropriate health care utilisation [20, 22]. However, there is scant information on existing gender disparities in utilising healthcare services among patients with chronic diseases in Bangladesh. As a result, this study aimed to examine the gender perspective of HCU among patients with chronic diseases in Bangladesh”. Please see page 5 (lines 7-24).

4. Methods: Data and information in the study is related to 2016-2017. My question is how to deal with the emerging burden of disease? In my opinion, if the data were used from a cohort study or from two consecutive censuses, the results would be more accurate and comprehensive.

Author’s response: The title has been revised to delete the terms “emerging”. It now reads, “The burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among patients in Bangladesh”.

5. Where can I find a list of chronic diseases? For example, in this section, there is no mentioned to kidney diseases.

Author’s response: Thank you for the insightful feedback. The main objective of this study was to examine disease-stratified healthcare utilisation (HCU) among Bangladesh patients with chronic diseases from a gender perspective. In the analytical exploration, the authors performed the disease-specific analysis of HCU by gender. For analysis, we recorded type of diseases based on the most reported but kidney diseases had a low frequency ones.

In this study, we did not report the prevalence for all diseases separately due to low frequency, including kidney diseases (Figure 2). Please see Figure 2.

6. The method of adjusting variables in models is confusing and unclear.

Author’s response: Before adjusting the variables in the final model 8, firstly we did the univariate analysis and then step-by-step multiple regression. That has been clearly described in the “Statistical Analysis” section. We have revised the methods section. Please see page 8-10.

7. Was regression or logistic regression used in this study?

Author’s response: We performed Logistic Regression. Please see page 8.

8. The method of initial selection of variables to enter the model is not clear.

Author’s Response: For the analytical exploration, the choice of estimation approach was informed by the nature of the outcome variables under consideration in each model. To build the regression model, explanatory variables were selected based on published literature [17,25–29], available information of this dataset and explored bivariate relationships (unadjusted analysis) between variables. In our analysis, we investigated individual-level data to estimate disease-specific healthcare utilisation due to chronic illness by gender prospective. We followed the standard procedure of independent variables selection for a model with the widely used cut-off value (p ≤ 0.05) in the unadjusted model. That has been clearly described in the “Statistical Analysis” section. Please see page 8-10.

9. The level of statistical significance should be less than 5% and not equal to 5%.

Author’s response: Thank you. Statistical significance was considered at ≤ 5% risk level. Please see page 10 (lines 7-8).

10. Results: Percentages should be written in numbers and not in letters.

Author’s response: It has now been written in numbers in the revised manuscript. Please see the revised manuscript.

11. The title of the article states that the study was conducted on adults, but the results indicate that almost 42% of people are young. This is a contradiction.

Author’s response: We have revised the title of this manuscript to remove the word “adult”. Currently it reads, “The burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among patients in Bangladesh”. Please see the revised title.

12. If one-third of patients had no formal education, how do they name their disease? The respondent is not known in this study.

Author’s response: Thank you for raising this issue. The present study used the HIES 2016-17 data. The survey procedures are comprehensively explained in the HIES 2016-17 final report. The survey was conducted by the Bangladesh Bureau of Statistics (BBS), which is one of the core national surveys implemented by the Bangladesh Government. The survey team formulated an operational definition of each of the variable used in the questionnaire and before conducting this survey, detailed training was provided to the enumerators and the supervisors on every aspect of the questionnaire including ways of collecting information, particularly from those having less educational attainments. The HIES survey tool was translated from English into the local (Bengali) language to ensure that participants understand the questions.

For example, while collecting chronic disease-related information, the enumerators were instructed to ask the respondents, "Have you suffered from any chronic illness/disability in the last 12 months or more?" (if yes); then, participants were asked a second question “What chronic illness/disability are you suffering from?” with response options: 1) chronic fever, 2) Injuries/disability, 3) Chronic heart disease, 4) Respiratory Diseases/ Asthma/Bronchitis, 5) Diarrhoea/dysentery, 6) Gastric/ulcer, 7) Blood pressure, 8) Arthritis/Rheumatism, 9) Skin problem, 10) Diabetes, 11) Cancer, 12) Kidney diseases, 13) Liver Diseases, 14) Mental Health, 15) Paralysis, 16) Ear/ENT problem, 17) Eye problem, or 18 other (specify). Participants responded based on their disease diagnosis, experiences, symptoms of illness and course of treatment. In order to get valid information, the enumerators also probed where necessary, asked the respondents to show any relevant documents e.g., prescriptions and test reports, or explained to the respondents about chronic diseases using various case scenarios as outlined in the survey guidelines and instructions. Please see page 7-8.

13. In this section was stated that “The utilisation of health care reduced as patients aged”. Has a statistical test been performed?

Authors’ response: Thank you for your comment. The distribution of HCU for chronic diseases within the background characteristics of the participants by gender is presented in Table 1. We found that the utilisation of health care was reduced as patients aged, which only the descriptive data. We did not perform any statistical test, which is outside the scope of this research objective.

14. In the division of chronic diseases (see Table 1), there is a group called "others", which is about 28% of patients. I think this group should be divided into more specific subgroups.

Authors’ response: Thank you. We have developed a new figure (Figure 2) to show the distribution of chronic diseases. In the analytical exploration, the authors’ performed disease-specific analysis in terms of HCU by gender. For conducting analysis, we recorded type of diseases based on the most privilege of reported diseases. However, in the HIES data, a high number of people reported “others” chronic disease without specifying the type of disease they suffered from. In this study, we did not report the prevalence of all diseases due to low frequency (Figure 2). Therefore, we have considered the most prevalent chronic diseases in our study.. We have added this information in the limitation. Please see the revise manuscript (page 15, lines 6-8).

15. Final: This manuscript does not have enough coherence. The title of the study is not in line with the final results and conclusions. Therefore, it cannot be published.

Authors’ response: We highly appreciate the reviewers' insightful and helpful comments on our manuscript. This manuscript has been revised substantially and we strongly believe that the comments and suggestions have increased the scientific value of revised manuscript in line standards. We believe you would reconsider your decision and accept our revision. Please see the revised manuscript.

References:

1. Hossain A, Alam MJ, Mydam J, Tareque M. Do the issues of religious minority and coastal climate crisis increase the burden of chronic illness in Bangladesh? BMC Public Health. 2022;22: 1–19. doi:10.1186/s12889-022-12656-5

2. Imtiaz A, Khan NM, Hasan E, Johnson S, Nessa HT. Patients’ choice of healthcare providers and predictors of modern healthcare utilisation in Bangladesh: Household Income and Expenditure Survey (HIES) 2016-2017 (BBS). BMJ Open. 2021;11: 1–10. doi:10.1136/bmjopen-2021-051434

3. Kastor A, Mohanty SK. Disease-specific out-of-pocket and catastrophic health expenditure on hospitalization in India: Do Indian households face distress health financing? PLoS One. 2018;13: 1–18. doi:10.1371/journal.pone.0196106

4. Sheikh N, Sarker AR, Sultana M, Mahumud RA, Ahmed S. Disease ‑ specific distress healthcare financing and catastrophic out ‑ of ‑ pocket expenditure for hospitalization in Bangladesh. 2022; 1–16. doi:10.1186/s12939-022-01712-6

5. Sultana M, Mahumud RA, Sarker AR. Burden of chronic illness and associated disabilities in Bangladesh: Evidence from the Household Income and Expenditure Survey. Chronic Dis Transl Med. 2017;3: 112–122. doi:10.1016/j.cdtm.2017.02.001

6. Ahmad S, Maqbool PA. Health Seeking Behaviour and Health Service Utilization in Lucknow. SSRN Electron J. 2013. doi:10.2139/ssrn.2326415

Attachment

Submitted filename: Response to the reviewer comments_v1.docx

Decision Letter 1

Tarik A Rashid

5 Feb 2023

PONE-D-22-15927R1The burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among patients in BangladeshPLOS ONE

Dear Dr. Mahumud,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

ACADEMIC EDITOR: Make sure to address the comments made by reviewer #1 in the relation to accessing original data as you need to address the required revisions. 

Please submit your revised manuscript by Mar 22 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Tarik A. Rashid, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thanks for the reply of the distinguished authors. According to the reply letter and the revised paper, it seems the author do not appropriate access to the original data; so that the revised paper does not address the required revisions. For instance, the matter of recruitment of the individuals from the households, it is not clear how many people were recruited from each household so that the matter of intraclass correlation is not clarified in the response. this is true for other requested revisions by the two reviewers.

Reviewer #2: I have matched all the authors' corrections with my own comments. All comments have been addressed by authors. In my opinion, given the corrections made, this manuscript is publishable.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: babak eshrati

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Accepted.docx

PLoS One. 2023 May 2;18(5):e0284117. doi: 10.1371/journal.pone.0284117.r004

Author response to Decision Letter 1


19 Feb 2023

Date: 20/02/2023

Dr Tarik A. Rashid

Academic Editor

PLOS ONE

Response to Reviewers’ comments on Manuscript Number: PONE-D-22-15927R2

The revised title of the manuscript: "The burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among patients in Bangladesh".

Dear Dr. Rashid

Thank you for the opportunity to revise our manuscript. We found the reviewers' comments and feedback very helpful in improving the manuscript and we have revised the manuscript accordingly. Please find below our point–by–point responses to each of the reviewers' comments. In addition, we have changed and updated the references list to provide appropriate and correct references. As a result, some of the references has been changed. Two versions of our paper – one clean copy, and one with marked-up (TC) copy showing the changes made – are submitted.

We look forward to hearing from you.

Yours sincerely,

Dr Rashidul Alam Mahumud (corresponding author)

On behalf of all co-authors

Response to the Editor Comments

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Authors’ response:

Thanks. We have checked all references and corrected them where appropriate and necessary. Please see the updated and corrected references list.

Response to Reviewer #1

Reviewer #1: Thanks for the reply of the distinguished authors. According to the reply letter and the revised paper, it seems the author do not appropriate access to the original data; so that the revised paper does not address the required revisions. For instance, the matter of recruitment of the individuals from the households, it is not clear how many people were recruited from each household so that the matter of intraclass correlation is not clarified in the response. this is true for other requested revisions by the two reviewers.

Author’s Response: Thank you very much for your comment.

We provided one section about the Availability of data and materials.

It reads: “Bangladesh Household Income and Expenditure Survey (HIES) is conducted by the Bangladesh Bureau of Statistics (BBS) with technical and financial support from the World Bank. This research was carried out using the 2016-2017 Bangladesh Household Income and Expenditure Survey. However, the BBS imposed legal restrictions that prevent the sharing of data publicly. Data can be shared upon request to the corresponding author with the permission of the BBS (Director General, Bangladesh Bureau of Statistics, dg@bbs.gov.bd, +88-02-5500-7056, www.bbs.gov.bd)”. Please see page 19 (lines 12-19).

We are more than happy to reply again this same comment as we did before. Our study was designed and structured based on examining disease-stratified healthcare utilisation (HCU) among Bangladesh patients with chronic diseases from a gender perspective. The entire dataset for this study consisting of 12,005 patients with diagnosed chronic diseases, has been collected from a nationally representative Household Income and Expenditure Survey (HIES), 2016-17 data. This dataset is open, well-structured, very popular, and rigorously used for different publications worldwide. In our study, we have selected the individuals from the households based on the following conditions: i) an individual who had suffered from any chronic disease for the last 12 months or more, ii) an individual who suffered from any chronic diseases or chronic conditions in the last 30 days, and iii) individual who received any treatment due to chronic illness in the last 30 days.

This study used individual-level data (not focusing on the households) to explore who has been exposed to any chronic disease. Therefore, It was not necessary to keep track of how many households were occupied by the overall sample population, which is out of the scope of this study. Please see page 6 (lines 19-24).

Response to Reviewer #2

Reviewer #2: I have matched all the authors' corrections with my own comments. All comments have been addressed by the authors. In my opinion, given the corrections made, this manuscript is publishable.

Author’s Response: Thanks. All of the reviewer’s comments help improve the quality of this manuscript.

Decision Letter 2

Tarik A Rashid

27 Mar 2023

The burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among patients in Bangladesh

PONE-D-22-15927R2

Dear Dr. Mahumud,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tarik A. Rashid, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Tarik A Rashid

19 Apr 2023

PONE-D-22-15927R2

The burden of chronic diseases, disease-stratified exploration and gender-differentiated healthcare utilisation among patients in Bangladesh

Dear Dr. Mahumud:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Tarik A. Rashid

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to the reviewer comments_v1.docx

    Attachment

    Submitted filename: Accepted.docx

    Data Availability Statement

    Bangladesh Household Income and Expenditure Survey (HIES) is conducted by the Bangladesh Bureau of Statistics (BBS) with technical and financial support from the World Bank. This research was carried out using the 2016-2017 Bangladesh Household Income and Expenditure Survey. However, the BBS imposed legal restrictions that prevent the sharing of data publicly. Data can be shared upon request to the corresponding author with the permission of the BBS (Director General, Bangladesh Bureau of Statistics, dg@bbs.gov.bd, +88-02-5500-7056, www.bbs.gov.bd).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES